Neurofeedback is a non-invasive treatment that encourages the brain to develop healthier patterns of activity. The goal of treatment is not only to change how one think and feel, but also to change brain on a biological level for better functioning. Neurofeedback is a method that assists subjects to control their brain waves consciously. While getting neurofeedback, electroencephalography (EEG) is actually being recorded. Then, its many components are separated and provided to participants via an online feedback loop as audio, video, or a combination of both. Electrical impulses called brain waves are employed by brain cells as a form of communication. Each brain wave has two distinct properties: frequency, or how quickly it moves, and amplitude, or how high it rises and falls. Faster brain waves are typically related with focus, thinking, and consciousness, while slower brain waves are typically associated with relaxation, meditation, and deep sleep. Neurofeedback is frequently used to treat brain wave dysregulation brought on by traumatic situations. For social and emotional deficiencies such conduct disorder, autism, and reactive attachment disorder, right-side training is also used.

A complementary therapy for psychiatric conditions such as attention-deficit/hyperactivity disorder, anxiety disorder, posttraumatic stress disorder, phobic disorder, obsessive-compulsive disorder, bipolar disorder, depression and affective disorders, autism, and addictive disorders, neurofeedback is also known as electroencephalogram (EEG) biofeedback or neurotherapy.

Market Dynamics

Increasing prevalence of mental disorders such as schizophrenia, anxiety and others is expected to drive the growth of the global neurofeedback market over the forecast period. For instance, data published on 10 January 2022, by WHO, stated that every year, schizophrenia affects around 24 million people or 1 in 300 people (0.32%) worldwide.

Key features of the study:

• This report provides in-depth analysis of the global neurofeedback market and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global neurofeedback market,  based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Neuro Care Group, Myndlift Ltd, Brainmaster Technologies, Inc., Mitsar Co. Ltd, Emotiv, Brainworks, Mindfield Biosystems Ltd. , Narbis, Thought Technology Ltd., InteraXon Inc., Mind Media USA Inc., and NeuralScan
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global neurofeedback market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurofeedback market.

Detailed Segmentation:

• Global Neurofeedback Market, By Product:
  • Amplifiers
  • Electrodes or Sensors
  • Computer Software
• Global Neurofeedback Market, By System:
  • Frequency/Power Neurofeedback System
  • Slow Cortical Potential Neurofeedback (SCP-NF) System
  • Low-Energy Neurofeedback System (LENS)
  • Hemoencephalographic (HEG) Neurofeedback System
  • Live Z-Score Neurofeedback System
  • Low-Resolution Electromagnetic Tomography (LORE-TA)
  • Functional Magnetic Resonance Imaging (fMRI)
• Global Neurofeedback Market By Application:
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Anxiety
  • Depression
  • Epilepsy
  • Insomnia
  • Drug Addiction
  • Schizophrenia
  • Others
• Global Neurofeedback Market By End User:
  • Hospitals
  • Ambulatory Surgical Center
  • Clinics
  • Others
• Global Neurofeedback Market, By Region:
  • North America
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Neuro Care Group*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Myndlift Ltd
  • Brainmaster Technologies, Inc
  • Mitsar Co. Ltd
  • Emotiv
  • Brainworks
  • Mindfield Biosystems Ltd.
  • Narbis
  • Thought Technology Ltd.
  • InteraXon Inc
  • Mind Media USA Inc
  • NeuralScan

 “*” marked represents similar segmentation in other categories in the respective section.